Arkolith/Insider Trading/CLDI/Form 4

Schoeneck James A

DirectorCalidi Biotherapeutics, Inc. (CLDI) · full profile →Form 4 · filed Apr 22, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 18, 2024Grant(A)375K$0.40$150K416K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 18, 2024Grant(A)375K——375K
Apr 18, 2024Grant(A)375K——375K
Apr 18, 2024Grant(A)375K——375K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-015572) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML